Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Vekacia demonstrates efficacy in vernal keratoconjunctivitis phase III trial

April 11, 2007

MM-093 begins pilot study in autoimmune uveitis

April 11, 2007

LX-201 begins pivotal trials

April 10, 2007

Lilly withdraws E.U. marketing authorization application for Arxxant

April 10, 2007

Santen seeks European approval of tafluprost

April 4, 2007

Lucentis launched in the U.K.

April 4, 2007

IND clearance sought for phase II ophthalmic study of Tbeta4 eye drops

April 4, 2007

New experimental approaches in glaucoma therapy

April 2, 2007

Acuity, Froptix and eXegenics to merge to form Opko

April 2, 2007

PF-03187207 begins clinical testing for glaucoma

April 2, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...